EMD-4590

Single-particle
2.8 Å
EMD-4590 Deposition: 01/02/2019
Map released: 17/04/2019
Last modified: 15/05/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-4590

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-6qm7 summary report (pdf.gz) Map-6qm7 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Leishmania tarentolae proteasome 20S subunit complexed with GSK3494245

EMD-4590

Single-particle
2.8 Å
EMD-4590 Deposition: 01/02/2019
Map released: 17/04/2019
Last modified: 15/05/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Leishmania tarentolae
Sample: Proteasome 20S subunit
Fitted models: 6qm7

Deposition Authors: Rowland P, Goswami P
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.
PUBMED: 30962368
DOI: doi:10.1073/pnas.1820175116
ISSN: 1091-6490
ASTM: PNASA6